Abstract
The human plasma platelet-activating factor acetylhydrolase (PAF acetylhydrolase, l-alkyl-2-acetyl-glycerophosphocholine esterase, l-alkyl-2-acetyl-sn-glycero-3-phosphocholine acetohydrolase, EC 3.1.1.47) is a phospholipase A2 activity discovered by its ability to hydrolyze PAF in serum derived from IgE-sensitized rabbits (see Fig. 1, and ref. 1). The cloning and characterization of the plasma PAF acetylhydrolase (2) resulted in its classification as a group VII phospholipase A2, based on its substrate specificity, amino acid sequence, and calcium independence (3). This enzyme recognizes primarily one feature in phospholipid substrates: the type of acyl group at the second position of the glycerol backbone (4). For hydrolysis to occur, this group has to be no longer than nine methylene groups in length (see Fig. 1, and ref. 5). In addition, species containing sn-2 groups with oxidized terminal functions (i.e., an acidic or aldehydic group) are better substrates (see Fig. 1, and ref. 6). However, phospholipids containing long acyl groups at the sn-2 position, such as those found in plasma and organelle membranes, are not hydrolyzed (7). These combined features ensure that phospholipid components of cellular membranes and lipoproteins remain intact, while products of oxidation and fragmentation of these lipids are hydrolyzed. Thus, it would be more appropriate to refer to PAF acetylhydrolase as short/oxidized sn-2 phospholipid hydrolase.
Keywords
- Polymerase Chain Reaction Fragment
- Sepharose Fast Flow
- Sodium Acetate Solution
- Sepharose Fast Flow Column
- Design Polymerase Chain Reaction Primer
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Farr, R. S., Cox, C. P., Wardlow, M. L., and Jorgensen, R. J (1980) Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin. Immunol. Immunopathol. 15, 318–330.
Tjoelker, L. W., Wilder, C, Eberhardt, C, Stafforini, D. M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L S., Zimmerman, G. A., Yamada, Y., McIntyre, T. M., Prescott, S. M., and Gray, P. W. (1995) Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374, 549–552.
Dennis, E. A. (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Bioch. Sci. 22, 1–3.
Stafforini, D. M., Prescott, S. M., and McIntyre, T. M. (1987) Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J. Biol. Chem. 262, 4223–230.
Stremler, K. E., Stafforini, D. M., Prescott, S. M., Zimmerman, G. A., and McIntyre, T. M. (1989) An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264, 5331–5334.
Stremler, K. E., Stafforini, D. M., Prescott, S. M., and McIntyre, T. M. (1991) Human plasma platelet-activating factor acetylhydrolase. Oxidatively-fragmented phospholipids as substrates. J. Biol. Chem. 266, 11,095–11,103.
Wardlow, M. L., Cox, C. P., Meng, K. E., Greene, D. E., and Farr, R. S. (1986) Substrate specificity and partial characterization of the PAF acylhydrolase in human serum that rapidly inactivates platelet-activating factor. J. Immunol. 136, 3441–3446.
Farr, R. S., Wardlow, M. L., Cox, C. P., Meng, K. E., and Greene, D. E. (1983) Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Federation Proc. 42, 3120–3122.
Stafforini, D. M., McIntyre, T. M., Carter, M. E., and Prescott, S. M. (1987) Human plasma platelet-activating factor acetylhydrolase: Association with lipoproteins and role in the degradation of platelet-activating factor. J. Biol. Chem. 262, 4215–222.
Tjoelker, L. W., Eberhardt, C, Unger, J., Trong, H.L., Zimmerman, G. A., McIntyre, T. M., Stafforini, D. M., Prescott, S. M., and Gray, P. W. (1995) Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270, 25,481–25,487.
Stafforini, D. M., Prescott, S. M., Zimmerman, G. A., and McIntyre, T. M. (1996) Mammalian platelet-activating factor acetylhydrolases. Biochim. Biophys. Acta 1301, 161–173.
Satoh, K., Imaizumi, T.-A., Kawamura, Y., Yoshida, H., Hiramoto, M., Takamatsu, S., and Takamatsu, M. (1991) Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. J. Clin. Invest. 87, 476–481.
Stafforini, D. M., Elstad, M. R., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. (1990) Human macrophages secrete platelet-activating factor acetylhydrolase. J. Biol. Chem. 265, 9682–9687.
Hattori, M., Arai, H., and Inoue. K. (1993) Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 268, 18,748–18,753.
Stafforini, D. M., Prescott, S. M., Zimmerman, G. A. and McIntyre, T. M. (1991) Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26, 979–985.
Stafforini, D. M., McIntyre, T. M., and Prescott, S. M. (1990) Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 187, 344–357.
Stafforini, D. M., Carter, M. E., Zimmerman, G. A., McIntyre, T. M., and Prescott, S. M. (1989) Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Proc. Natl. Acad. Sci. USA 8, 2393–2397.
Miozzari, G. F. and Yanofsky, C. (1978) Translation of the leader region of the Escherichia coli tryptophan operon. J. Bact. 133, 1457–1466.
Sambrook, J., Fritsch, E. F., and Maniatis, T (1982) Molecular Cloning: A Laboratory Manual (Nolan, C, ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Blank, M. L., Lee, T.-C, Fitzgerald, V., and Snyder, F. (1981) A specific acetylhydrolase for l-alkyl-2-acetyl-sn-glycero-3-phopshocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256, 175–178.
Miwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y., and Matsumoto M. (1988) Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82, 1983–1991.
Bligh, E. G. and Dyer, W. F. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917.
Mueller, H. W., O’Flaherty, J. T., and Wykle, R. L. (1983) Biosynthesis of Platelet-activating factor in rabbit polymorphonuclear neutrophils. J. Biol. Chem. 258, 6213–6218.
Brash, A. R., Ingram, C. D., and Harris, T. M. (1987) Analysis of a specific oxygenation reaction of soybean lipoxygenase-1 with fatty acids esterified in phospholipids. Biochemistiy 26, 5465–5471.
Liljestrom, P. and Garoff, H. (1994) Protein expression, in Current Protocols in Molecular Biology (Ausubel, F. M, Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J., Struhl, K., eds.), Wiley, New York, pp. 16.0.1–16.20.16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Stafforini, D.M., Tjoelker, L.W. (1999). Human Plasma Platelet-Activating Factor Acetylhydrolase. In: Doolittle, M., Reue, K. (eds) Lipase and Phospholipase Protocols. Methods in Molecular Biology™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-581-2:49
Download citation
DOI: https://doi.org/10.1385/1-59259-581-2:49
Publisher Name: Humana Press
Print ISBN: 978-0-89603-546-1
Online ISBN: 978-1-59259-581-5
eBook Packages: Springer Protocols